Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
218 studies found for:    YOUNG SYNDROME
Show Display Options
Rank Status Study
1 Completed Symbolic Representation in Young Children With Down Syndrome
Condition: Down Syndrome
Intervention:
2 Recruiting Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children
Condition: Down Syndrome
Intervention: Drug: thyroid hormone and folinic acid
3 Recruiting Risk of Diabetes in Young Turner Syndrome Patients
Condition: Turner Syndrome
Intervention:
4 Completed Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
Condition: Irritable Bowel Syndrome
Intervention:
5 Completed Iyengar Yoga for Young People With Irritable Bowel Syndrome
Condition: Irritable Bowel Syndrome
Intervention: Behavioral: Iyengar yoga
6 Completed Water Beverage Intervention Trial for Reducing Risk Factors of Metabolic Syndrome in Young Mexican Free Living Women
Condition: Metabolic Syndrome
Interventions: Other: Water;   Other: Education
7 Recruiting Multicenter Evaluation of Children and Young Adults With Genotype Positive Long QT Syndrome
Condition: Long QT Syndrome
Intervention:
8 Terminated
Has Results
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
Condition: Prader-Willi Syndrome
Interventions: Drug: Octreotide;   Drug: Placebo
9 Completed
Has Results
Efficacy and Safety of Memantine Hydrochloride in Enhancing the Cognitive Abilities of Young Adults With Down Syndrome
Condition: Down Syndrome
Interventions: Drug: Memantine;   Drug: Placebo
10 Completed Verapamil as Therapy for Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Verapamil
11 Completed n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Interventions: Dietary Supplement: LC n-3 PUFA (fish oil) Supplement;   Dietary Supplement: Placebo (olive oil) supplement
12 Completed
Has Results
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
Condition: Down Syndrome
Interventions: Drug: ELND005;   Drug: Placebo
13 Recruiting Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
Condition: Polycystic Ovary Syndrome
Interventions: Behavioral: Taichi;   Behavioral: Self-monitored exercise
14 Recruiting Auricular Acupressure (AA) For Overweight/Obese Adolescent and Young Polycystic Ovary Syndrome ( PCOS)
Condition: Polycystic Ovary Syndrome
Interventions: Other: Auricular acupressure;   Other: Placebo auricular acupressure
15 Recruiting A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: ZX008 - 0.8 mg/kg/day;   Drug: ZX008 - 0.2 mg/kg/day;   Drug: Placebo
16 Enrolling by invitation An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: ZX008 (Fenfluramine Hydrochloride)
17 Completed Patellar Taping on Proprioceptive Exercises in Young Women With Patellofemoral Pain Syndrome
Condition: Anterior Knee Pain Syndrome
Interventions: Other: Intervention taping;   Other: Placebo Taping
18 Completed Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years
Condition: Turner's Syndrome
Interventions: Other: 0.15 IU/kg/day GH;   Other: 0.1 IU/kg/day GH
19 Recruiting A Two-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥2 Years Old and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Interventions: Drug: ZX008 - 0.2 mg/kg/day;   Drug: ZX008 - 0.4 mg/kg/day;   Drug: ZX008 - 30 mg/kg/day maximum dose;   Drug: Matching Placebo
20 Active, not recruiting Assessing Inherited Markers of Metabolic Syndrome in the Young
Conditions: Metabolic Syndrome;   Diabetes Mellitus, Type 2;   Obesity
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.